Login
Rezent Neiegkeeten

Nasdaq 100 Präisanalyse - 12. Februar

Nasdaq 100 Präisanalyse - 12. Februar
Titel

Nasdaq 100 Präisanalyse - 4. Dezember

Wall Street hat en Donneschdeg eng positiv Sessioun, mat den Nasdaq 100 (NDX) an S&P 500 (SPX) déi nei All-Time Highs opgeholl hunn. Wéi och ëmmer, d'Stéierrally gouf ofgeschnidden no engem Bericht iwwer Verdeelungsproblemer mam Pfizer (NYSE: PFE) COVID-19 Impfung. Den Nasdaq 100 huet gëschter en neien ATH ronderëm 12,539 gebucht ier hien op den 12,450 [...]

méi liesen
Titel

Nasdaq 100 Präisanalyse - 1. Dezember

The Nasdaq 100 (NDX) has rounded off November on a positive note, after the month up by more than 11%. This surge was mainly stimulated by the recently-concluded US Presidential election and the discovery of potential COVID-19 vaccines. These themes were the major dominating fundamental factors through November, as hopes for things to go back […]

méi liesen
Titel

Nasdaq 100 Präisanalyse - 27. November

Wall Street traded on a mixed sentiment on Wednesday as the Thanksgiving Holiday in the US drew near. Yesterday was Thanksgiving in the US, and markets across the country were closed. Most sectors under the S&P 500 (SPX) traded lower on Wednesday, with Energy stocks and Consumer Stables leading the decline. The Nasdaq 100 (NDX) […]

méi liesen
Titel

Nasdaq 100 kritt e Boost wéi d'US Gesetzgeber de COVID-19 Stimulus Gespréicher erëmfannen

US equity indexes closed higher on Thursday, as investors’ market confidence got revitalized following mentions of Washington lawmakers coming back together to pass a Coronavirus fiscal stimulus package to ease the pandemic-induced economic crisis. The Nasdaq 100 (NDX) rose by 90.72 points or (0.76)and closed at 11985.43, while the Dow Jones (DJIA) and S&P 500 […]

méi liesen
Titel

Nasdaq 100 Präisanalyse - 17. November

Den Nasdaq 100 (NDX) huet op enger positiver Note bis e Méindeg gehandelt an ass méiglecherweis seng bullish Rees an der Nordamerikanescher Sessioun um Dënschdeg erëmzefannen. Den Index huet dës Woch op e ganz positive Fouss ugefaang, well Maartparticipanten e Widderhuelung vum Bullrun vun der leschter Woch an enger weiderer COVID-19 Impfung-verbonne Entwécklung erwaarden. Den […]

méi liesen
Titel

Nasdaq 100 hëlt Bullish Damp op wéi den COVID-19 Impfungsoptimismus erofgeet

The recent market shift away from the tech sector into traditional value stocks following the positive COVID-19 news could be short-lived. Investors have trooped into value stocks after a COVID-19 vaccine being developed by Pfizer showed 90% effectiveness against the novel disease. This bolstered companies with a traditional business model, especially at a time when […]

méi liesen
Titel

Positiv Impfentwécklung fir den Tech-Heavy Nasdaq 100 op eng Downward Spiral ze schécken

US equity markets went into a frenzy on Monday, following positive results and reporting of a COVID-19 vaccine candidate by Pfizer (NYSE: PFE). The company’s mRNA technology-based vaccine showed a 90% effectiveness result in an initial phase 3 clinical trial. The result was largely better-than-expected, although there are worries that its effectivity could depreciate as […]

méi liesen
1 2 3 4 ... 7
Hëllefe profitéieren
Hëllefe profitéieren
Frësch
Frësch
Krypto
Crypto
algo
Eppes
Neiegkeeten
Neiegkeeten